Genetic Analysis

Ticker/ISIN
GEAN
NO0010692130
Marknad/Land
Spotlight
Sweden
Om Genetic Analysis
Genetic Analysis är verksamma inom medicinteknik. Bolaget bedriver forskning och utveckling inom området för diagnostik, med störst fokus mot mänsklig mikrobiomet. Tekniken utgår ifrån bolagets forskningsplattform och IVD-produkterna används exempelvis för testtagning och analys av bakterier och virus. Störst verksamhet återfinns inom den nordiska marknaden och produkterna vidaresäljs huvudsakligen till laboratorier. Bolaget har sitt huvudkontor i Oslo, Norge.
Senaste sammanfattade pressmeddelande från Genetic Analysis
Genetic Analysis (GA), under CEO Ronny Hermansen, reported record sales in Q4 2024, with a 63% increase compared to the previous year, reaching NOK 6.2 million. The company achieved its first positive EBITDA of NOK 0.4 million, marking a significant milestone. The GA-map® Dysbiosis Test sales grew 49% in Q4 and 37% YTD. A major agreement with Ferring Pharmaceuticals was signed to develop a new microbiome-based diagnostic test, targeting a launch in H1 2025. Financial highlights include an operating income of NOK 7.3 million in Q4, with a net loss of NOK 0.9 million. Operating costs decreased by 37% in Q4, attributed to reduced R&D expenses and general cost cuts. Significant events included share purchases by GA’s Head of Operations and CEO, and a collaboration with Ferring Pharmaceuticals to develop a new PCR test. No significant events were reported after the period. GA aims to lead in standardized gut microbiota testing globally.
Threads
Press release from Companies: Genetic Analysis AS achieves Thai FDA License for GA-map[®] Dysbiosis Test in Thailand
Press release from Companies: Genetic Analysis AS ingår avtal med Microbiome Research Pvt. Ltd. för att lansera GA-map[®]-tekniken i Indien
Press release from Companies: Genetic Analysis AS enters an agreement with Microbiome Research Pvt. Ltd. to launch GA-map[®] technology in India
Press release from Companies: Genetic Analysis ingår avtal med Hausen Bernstein om lansering av GA-map[®] i Thailand
Press release from Companies: Genetic Analysis AS enters an agreement with Hausen Bernstein Co. Ltd. to launch GA-map[®] technology in Thailand
Press release from Companies: Genetic Analysis AS offentliggör utfall i optionsinlösen
Press release from Companies: Genetic Analysis AS announces the outcome of the warrant exercise
Press release from Companies: Sista dag för handel med teckningsoptioner av serie TO 1 är den 14 november 2022
Press release from Companies: Last day of trading in warrants of series TO 1 is November 14, 2022
Market Notices: Market Notice 187/22– Last day of trading in Genetic Analysis As’s subscription option GEAN TO 1